These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26391285)

  • 21. Relation between jumping to conclusions and cognitive functioning in people with schizophrenia in contrast with healthy participants.
    Ochoa S; Haro JM; Huerta-Ramos E; Cuevas-Esteban J; Stephan-Otto C; Usall J; Nieto L; Brebion G
    Schizophr Res; 2014 Oct; 159(1):211-7. PubMed ID: 25112159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission and cognitive ability in a cohort of patients with schizophrenia.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    J Psychiatr Res; 2006 Dec; 40(8):738-45. PubMed ID: 16963087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
    Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
    Réthelyi JM; Czobor P; Polgár P; Mersich B; Bálint S; Jekkel E; Magyar K; Mészáros A; Fábián A; Bitter I
    Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):107-15. PubMed ID: 21792534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Bergh S; Hjorthøj C; Sørensen HJ; Fagerlund B; Austin S; Secher RG; Jepsen JR; Nordentoft M
    Schizophr Res; 2016 Aug; 175(1-3):57-63. PubMed ID: 27050475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Hui CL; Chan SK; Lee EH; Wong GH; Chen EY
    Schizophr Res; 2014 Jan; 152(1):146-51. PubMed ID: 24333004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.
    Chen EY; Hui CL; Dunn EL; Miao MY; Yeung WS; Wong CK; Chan WF; Tang WN
    Schizophr Res; 2005 Sep; 77(1):99-104. PubMed ID: 16005389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study.
    Wright B; Peters E; Ettinger U; Kuipers E; Kumari V
    Schizophr Res; 2016 May; 173(1-2):101-8. PubMed ID: 27017491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia.
    Pegoraro LFL; Dantas CR; Banzato CEM; Fuentes D
    Schizophr Res; 2013 Jun; 147(1):91-94. PubMed ID: 23535076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smaller than expected cognitive deficits in schizophrenia patients from the population-representative ABC catchment cohort.
    Lennertz L; An der Heiden W; Kronacher R; Schulze-Rauschenbach S; Maier W; Häfner H; Wagner M
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):423-31. PubMed ID: 26233432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
    Tan EJ; Rossell SL
    Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
    Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
    Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.